Developing executive presence doesn’t just make us better leaders; it helps us have more intentional, connected and ...
Discover a study exploring acquired ICI resistance in melanoma and how CNV-driven mechanisms inform clinical strategies.
Researchers have discovered quantum oscillations inside an insulating material, overturning long-held assumptions. Their work at the National Magnetic Field Laboratory suggests that the effect ...
Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI.
Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...
Meg Alexander appointed Chief Executive Officer effective January 1, 2026; Dr. Jeremy M. Levin to transition to Executive Chair of the Board of DirectorsNext-generation GABA-aminotransferase (GABA-AT) ...
Meg Alexander appointed Chief Executive Officer effective January 1, 2026; Dr. Jeremy M. Levin to transition to Executive Chair of the Board of DirectorsNext-generation GABA-aminotransferase (GABA-AT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback